Telemedical Algorithm-Supported Care for Hypertension
SOT-ART-HT
Telemedical Care System for the Treatment of Arterial Hypertension Using Recommendation Algorithms to Support Diagnostic and Therapeutic Decisions
1 other identifier
interventional
200
1 country
1
Brief Summary
Hypertension is a major global health issue, affecting around 9 million people in Poland. While some studies indicate that telemonitoring benefits patients with hypertension, there is a lack of research evaluating tools that assist doctors in managing these patients. The objective of this study is to assess a blood pressure monitoring system with an integrated algorithm that aids doctors in the decision-making process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 4, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 9, 2024
November 1, 2024
3.3 years
December 4, 2024
December 4, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Assessment of Achieving Arterial Blood Pressure Control
Time from study initiation to the day of achieving arterial blood pressure control, defined as a 7-day mean of home blood pressure measurements below 135/85 mmHg
After completing the presumed six-month follow-up of the last participant
Assessment of Achieving Arterial Blood Pressure control at 6 months
The time from study initiation to 6 months of participation, achieving arterial blood pressure control, defined as a 7-day average of home blood pressure measurements below 135/85 mmHg
After 6 months of participating
Secondary Outcomes (4)
Assessment of blood pressure values in 24-hour monitoring, home measurements, and office measurements
Baseline up to approximately six-months of observation
Assessment of the number of the medical visits
After completing the presumed six-month follow-up of the last participant
Assessment of the maintaining blood pressure control
After completing the presumed six-month follow-up of the last participant
Assessment of the cost of visits
After completing the presumed six-month follow-up of the last participant
Study Arms (2)
Control group
NO INTERVENTIONStandard care involving regular visits to a hypertension clinic. Patients in the control group will receive standard care. They will have appointments according to the guidelines of the Polish Society of Hypertension -initially once a month and, after achieving control (i.e., blood pressure in office measurement \< 140/90 mmHg), once every 3 months.
Study group
EXPERIMENTALIn the intervention group, a care model using a system implementing an algorithm that supports therapeutic and diagnostic decisions made by the doctor in the care of patients with AH will be applied. The algorithm identifies patients who have or have not achieved therapeutic goals and suggests actions for specific patients, but the final therapeutic and diagnostic decisions are always made by the doctor. It is emphasized that the treating physician is not bound by the algorithm's recommendations.
Interventions
Receiving remote care facilitated by a specialized informatic system to support the physician
Eligibility Criteria
You may qualify if:
- Voluntarily signing an informed consent to participate in the study.
- Age between 18 and 80 years.
- Diagnosis of hypertension according to the Polish Society of Hypertension criteria from 2019, either already treated or newly diagnosed.
- Blood pressure exceeding 140/90 mmHg in office measurements (during the screening visit).
You may not qualify if:
- Suspicion or diagnosis of secondary hypertension.
- Pregnant women, breastfeeding women, or those planning pregnancy during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences
Poznan, 60-848, Poland
Related Publications (1)
Lipski D, Lewandowska K, Zurek S, Wisniewicz M, Pirog P, Tykarski A, Uruski P. Telemedical care system for the treatment of arterial hypertension using recommendation algorithms to support diagnostic and therapeutic decisions-study protocol for a single-center, randomized, controlled, open-label SOT-ART-HT trial. Trials. 2025 Sep 1;26(1):330. doi: 10.1186/s13063-025-09044-w.
PMID: 40890870DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2024
First Posted
December 9, 2024
Study Start
October 1, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 9, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share